Questions and answers
Clear answers for families, clinicians, researchers, funders, and early collaborators considering the Comic Journal concept.
Comic Journal is an early-stage graphic medicine concept that turns daily asthma check-ins into personalised comic stories. It is designed to help children and families approach medication routines, symptoms, barriers, and health conversations in a more engaging format.
A child and parent record medication use, symptoms, barriers, and daily experiences. Selected, minimised data points are mapped into a hero narrative in which visual metaphors reflect real events. Read the full Comic Journal process.
The proposed check-in can capture preventer inhaler use, symptoms, possible triggers, school or social barriers, treatment worries, forgetfulness, and practical reasons a routine was missed.
The first concept focuses on children and families managing asthma. The exact age range and pilot inclusion criteria still need to be confirmed through co-design and clinical review.
No. Comic Journal is evidence-informed, but it has not yet completed its own trial. The planned pilot is intended to explore engagement, asthma knowledge, trigger awareness, inhaler technique, reassurance, and acceptability. See the research behind the concept.
No. Comic Journal is intended to support learning and conversation. It does not replace prescribed treatment, a clinician, emergency guidance, or a Personalised Asthma Action Plan.
The intended model is device-first. Any information used for assisted story generation should be minimised, aggregated or anonymised, and processed securely with clear consent and retention rules. Read the privacy and UK GDPR principles.
Asthma is the first focus. If the approach is shown to be useful, later modules may explore other conditions and support needs. Any future autism-related work should be neuro-affirming, co-designed, and centred on self-understanding rather than compliance.
Yes. Comic Journal is seeking clinical and academic collaborators, workshop participants, beta testers, early adopters, and strategic funding partners. Email hello@boonandmoil.dev.